{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:05:57Z","timestamp":1790766357395,"version":"4.1.0"},"reference-count":64,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Morbidity and mortality of Philadelphia chromosome\u2013negative myeloproliferative neoplasms (MPNs) are mainly determined by thromboembolic complications. Thrombus formation is facilitated by a neutrophil-specific form of cell death linked to neutrophil extracellular trap (NET) formation (NETosis). Preclinical and clinical data suggested a potential link between NETosis and thrombosis in MPNs. In this study, we aimed to define the impact of NETosis on clinical end points in a large MPN cohort. NETosis was induced in vitro by ionomycin and quantified by enzyme-linked immunosorbent assay\u2013based nucleosome release assays as well as fluorescent staining of free DNA in samples from 103 MPN patients and 28 healthy donors. NETosis rate was correlated with a broad set of clinical data, such as MPN subtype, mutational status, laboratory variables, history of thrombotic events, and treatment types. Triggered NETosis levels were clearly higher in MPN patients than in healthy donors. Positivity for JAK2 V617F or exon 12 as well as CALR mutations correlate with increased NET formation. However, neither JAK2 allelic burden nor history of thromboembolic complication nor the presence of other risk factors for thrombosis (eg, leukocytosis) were associated with the rate of NETosis. In addition, none of the analyzed laboratory parameters nor the type of treatment significantly impacted the rate of NETosis formation. The biology of MPNs has an impact on NET formation because genetic driver mutations favor induction of NETosis, but this does not seems to translate into important clinical end points such as thromboembolic complications. Therefore, NETosis may play a role in facilitating thrombosis, but it is not a sole causative determinant in MPN-associated thrombophilia.<\/jats:p>","DOI":"10.1182\/bloodadvances.2020004061","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T21:58:25Z","timestamp":1630447105000},"page":"3515-3527","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":22,"title":["Increased levels of NETosis in myeloproliferative neoplasms are not linked to thrombotic events"],"prefix":"10.1182","volume":"5","author":[{"given":"Stefan","family":"Schmidt","sequence":"first","affiliation":[{"name":"Internal Medicine V, Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Daniliants","sequence":"additional","affiliation":[{"name":"Internal Medicine V, Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Hiller","sequence":"additional","affiliation":[{"name":"Internal Medicine V, Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1327-2921","authenticated-orcid":false,"given":"Eberhard","family":"Gunsilius","sequence":"additional","affiliation":[{"name":"Internal Medicine V, Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Wolf","sequence":"additional","affiliation":[{"name":"Internal Medicine V, Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria; and"},{"name":"Medical Clinic III, Oncology, Hematology, Immuno-Oncology and Rheumatology, University Clinic Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5182-7217","authenticated-orcid":false,"given":"Clemens","family":"Feistritzer","sequence":"additional","affiliation":[{"name":"Internal Medicine V, Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"2021091715292849700_B1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017","edition":"rev 4th ed"},{"issue":"10","key":"2021091715292849700_B2","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1515\/cclm-2013-0135","article-title":"Molecular basis and clonal evolution of myeloproliferative neoplasms","volume":"51","author":"Cleary","year":"2013","journal-title":"Clin Chem Lab Med"},{"issue":"12","key":"2021091715292849700_B3","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1182\/blood-2016-10-696005","article-title":"Myeloproliferative neoplasm stem cells","volume":"129","author":"Mead","year":"2017","journal-title":"Blood"},{"issue":"25","key":"2021091715292849700_B4","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms","volume":"369","author":"Klampfl","year":"2013","journal-title":"N Engl J Med"},{"issue":"15","key":"2021091715292849700_B5","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJMoa1716614","article-title":"Classification and personalized prognosis in myeloproliferative neoplasms","volume":"379","author":"Grinfeld","year":"2018","journal-title":"N Engl J Med"},{"issue":"17","key":"2021091715292849700_B6","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"issue":"10","key":"2021091715292849700_B7","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood-2015-11-681932","article-title":"Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants","volume":"127","author":"Chachoua","year":"2016","journal-title":"Blood"},{"issue":"7","key":"2021091715292849700_B8","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1371\/journal.pmed.0030270","article-title":"MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia","volume":"3","author":"Pikman","year":"2006","journal-title":"PLoS Med"},{"issue":"25","key":"2021091715292849700_B9","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1182\/blood.2019000622","article-title":"Mutant calreticulin in myeloproliferative neoplasms","volume":"134","author":"How","year":"2019","journal-title":"Blood"},{"issue":"1","key":"2021091715292849700_B10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1182\/asheducation-2016.1.552","article-title":"Mutations in MPNs: prognostic implications, window to biology, and impact on treatment decisions","volume":"2016","author":"Shammo","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"7037","key":"2021091715292849700_B11","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"issue":"4","key":"2021091715292849700_B12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"issue":"1","key":"2021091715292849700_B13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1479-5876-7-39","article-title":"Gene and microRNA analysis of neutrophils from patients with polycythemia vera and essential thrombocytosis: down-regulation of micro RNA-1 and -133a","volume":"7","author":"Slezak","year":"2009","journal-title":"J Transl Med"},{"issue":"1","key":"2021091715292849700_B14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13256-018-1955-x","article-title":"A serious thrombotic event in a patient with immune thrombocytopenia requiring intravenous immunoglobulin: a case report","volume":"13","author":"Rungjirajittranon","year":"2019","journal-title":"J Med Case Reports"},{"issue":"13","key":"2021091715292849700_B15","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood-2013-03-460154","article-title":"Myeloproliferative neoplasms and thrombosis","volume":"122","author":"Barbui","year":"2013","journal-title":"Blood"},{"issue":"11","key":"2021091715292849700_B16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s11910-014-0496-y","article-title":"Cerebral thrombosis and myeloproliferative neoplasms","volume":"14","author":"Artoni","year":"2014","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"2021091715292849700_B17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13045-016-0242-9","article-title":"Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry","volume":"9","author":"Kaifie","year":"2016","journal-title":"J Hematol Oncol"},{"issue":"5","key":"2021091715292849700_B18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/M17-0028","article-title":"Risk for arterial and venous thrombosis in patients with myeloproliferative neoplasms: A population-based cohort study","volume":"168","author":"Hultcrantz","year":"2018","journal-title":"Ann Intern Med"},{"issue":"20","key":"2021091715292849700_B19","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1200\/JCO.2014.57.6652","article-title":"Risk and cause of death in patients diagnosed with myeloproliferative neoplasms in Sweden between 1973 and 2005: A population-based study","volume":"33","author":"Hultcrantz","year":"2015","journal-title":"J Clin Oncol"},{"issue":"3","key":"2021091715292849700_B20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2040620716680333","article-title":"Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease","volume":"8","author":"How","year":"2017","journal-title":"Ther Adv Hematol"},{"issue":"25","key":"2021091715292849700_B21","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1182\/blood-2014-07-551515","article-title":"How I treat splanchnic vein thrombosis","volume":"124","author":"Ageno","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2021091715292849700_B22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1160\/th15-04-0326","article-title":"Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment","volume":"115","author":"De Stefano","year":"2016","journal-title":"Thromb Haemost"},{"issue":"6","key":"2021091715292849700_B23","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1182\/blood-2006-08-042515","article-title":"Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera","volume":"109","author":"Landolfi","year":"2007","journal-title":"Blood"},{"issue":"22","key":"2021091715292849700_B24","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1182\/blood-2011-02-339002","article-title":"Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients","volume":"117","author":"Carobbio","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2021091715292849700_B25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/bjh.14202","article-title":"Impact of white blood cell counts at diagnosis and during follow-up in patients with essential thrombocythaemia and prefibrotic primary myelofibrosis","volume":"179","author":"Buxhofer-Ausch","year":"2017","journal-title":"Br J Haematol"},{"issue":"26","key":"2021091715292849700_B26","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1182\/blood-2012-07-444067","article-title":"Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)","volume":"120","author":"Barbui","year":"2012","journal-title":"Blood"},{"issue":"4","key":"2021091715292849700_B27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2009.02.004","article-title":"Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review","volume":"124","author":"Lussana","year":"2009","journal-title":"Thromb Res"},{"issue":"4","key":"2021091715292849700_B28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.blre.2014.12.002","article-title":"Mechanisms of thrombogenesis in polycythemia vera","volume":"29","author":"Kroll","year":"2015","journal-title":"Blood Rev"},{"issue":"36","key":"2021091715292849700_B29","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2021091715292849700_B30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrm3737","article-title":"Regulated necrosis: the expanding network of non-apoptotic cell death pathways","volume":"15","author":"Vanden Berghe","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"2021091715292849700_B31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1083\/jcb.200606027","article-title":"Novel cell death program leads to neutrophil extracellular traps","volume":"176","author":"Fuchs","year":"2007","journal-title":"J Cell Biol"},{"issue":"5663","key":"2021091715292849700_B32","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"issue":"8","key":"2021091715292849700_B33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrmicro1710","article-title":"Beneficial suicide: why neutrophils die to make NETs","volume":"5","author":"Brinkmann","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"2021091715292849700_B34","doi-asserted-by":"crossref","first-page":"e0003927","DOI":"10.1371\/journal.pntd.0003927","article-title":"Neutrophil extracellular traps are involved in the innate immune response to infection with leptospira","volume":"9","author":"Scharrig","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"2021091715292849700_B35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mib.2006.12.005","article-title":"Neutrophil extracellular traps: casting the NET over pathogenesis","volume":"10","author":"Wartha","year":"2007","journal-title":"Curr Opin Microbiol"},{"issue":"3","key":"2021091715292849700_B36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/path.4660","article-title":"Neutrophil extracellular traps cause airway obstruction during respiratory syncytial virus disease","volume":"238","author":"Cortjens","year":"2016","journal-title":"J Pathol"},{"issue":"1","key":"2021091715292849700_B37","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12931-020-01425-w","article-title":"Host DNA released by NETosis in neutrophils exposed to seasonal H1N1 and highly pathogenic H5N1 influenza viruses","volume":"21","author":"Chan","year":"2020","journal-title":"Respir Res"},{"issue":"12","key":"2021091715292849700_B38","doi-asserted-by":"crossref","first-page":"e20201129","DOI":"10.1084\/jem.20201129","article-title":"SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology","volume":"217","author":"Veras","year":"2020","journal-title":"J Exp Med"},{"issue":"3","key":"2021091715292849700_B39","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.chom.2012.06.011","article-title":"Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis","volume":"12","author":"McDonald","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"5","key":"2021091715292849700_B40","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1083\/jcb.201203170","article-title":"Neutrophil extracellular traps: is immunity the second function of chromatin?","volume":"198","author":"Brinkmann","year":"2012","journal-title":"J Cell Biol"},{"issue":"7","key":"2021091715292849700_B41","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrneph.2016.71","article-title":"The role of neutrophils and NETosis in autoimmune and renal diseases","volume":"12","author":"Gupta","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"2021091715292849700_B42","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.autrev.2019.06.011","article-title":"An emerging role of neutrophils and NETosis in chronic inflammation and fibrosis in systemic lupus erythematosus (SLE) and ANCA-associated vasculitides (AAV): Implications for the pathogenesis and treatment","volume":"18","author":"Frangou","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"3","key":"2021091715292849700_B43","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jbspin.2016.05.013","article-title":"NETosis: At the crossroads of rheumatoid arthritis, lupus, and vasculitis","volume":"84","author":"Berthelot","year":"2017","journal-title":"Joint Bone Spine"},{"issue":"7","key":"2021091715292849700_B44","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/CIRCRESAHA.116.304944","article-title":"Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size","volume":"116","author":"Mangold","year":"2015","journal-title":"Circ Res"},{"issue":"8","key":"2021091715292849700_B45","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/ATVBAHA.113.301627","article-title":"Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state","volume":"33","author":"Borissoff","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2021091715292849700_B46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ana.24993","article-title":"Neutrophil extracellular traps in ischemic stroke thrombi","volume":"82","author":"Laridan","year":"2017","journal-title":"Ann Neurol"},{"issue":"10","key":"2021091715292849700_B47","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1161\/STROKEAHA.119.026373","article-title":"Circulating DNAs, a marker of neutrophil extracellular traposis and cancer-related stroke: The OASIS-Cancer study","volume":"50","author":"Bang","year":"2019","journal-title":"Stroke"},{"issue":"5","key":"2021091715292849700_B48","doi-asserted-by":"crossref","first-page":"e1134073","DOI":"10.1080\/2162402X.2015.1134073","article-title":"Priming of neutrophils toward NETosis promotes tumor growth","volume":"5","author":"Demers","year":"2016","journal-title":"OncoImmunology"},{"issue":"18","key":"2021091715292849700_B49","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1038\/onc.2016.406","article-title":"Neutrophil extracellular traps: protagonists of cancer progression?","volume":"36","author":"Erpenbeck","year":"2017","journal-title":"Oncogene"},{"key":"2021091715292849700_B50","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3389\/fimmu.2016.00373","article-title":"NETosis in cancer - platelet-neutrophil crosstalk promotes tumor-associated pathology","volume":"7","author":"Olsson","year":"2016","journal-title":"Front Immunol"},{"key":"2021091715292849700_B51","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fimmu.2017.00081","article-title":"Neutrophil extracellular traps and its implications in inflammation: An overview","volume":"8","author":"Delgado-Rizo","year":"2017","journal-title":"Front Immunol"},{"key":"2021091715292849700_B52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2019.06.919","article-title":"The pathway of neutrophil extracellular traps towards atherosclerosis and thrombosis","volume":"288","author":"Moschonas","year":"2019","journal-title":"Atherosclerosis"},{"issue":"3","key":"2021091715292849700_B53","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jth.13951","article-title":"Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients","volume":"16","author":"Mauracher","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2021091715292849700_B54","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nm.2184","article-title":"Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases","volume":"16","author":"Massberg","year":"2010","journal-title":"Nat Med"},{"issue":"1","key":"2021091715292849700_B55","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"436","key":"2021091715292849700_B56","doi-asserted-by":"crossref","first-page":"eaan8292","DOI":"10.1126\/scitranslmed.aan8292","article-title":"Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms","volume":"10","author":"Wolach","year":"2018","journal-title":"Sci Transl Med"},{"issue":"1","key":"2021091715292849700_B57","doi-asserted-by":"crossref","first-page":"38738","DOI":"10.1038\/srep38738","article-title":"Neutrophil extracellular trap formation and circulating nucleosomes in patients with chronic myeloproliferative neoplasms","volume":"6","author":"Marin Oyarz\u00fan","year":"2016","journal-title":"Sci Rep"},{"issue":"22","key":"2021091715292849700_B58","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1182\/blood-2014-02-554634","article-title":"Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis","volume":"123","author":"Rampal","year":"2014","journal-title":"Blood"},{"issue":"4","key":"2021091715292849700_B59","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1084\/jem.20112322","article-title":"Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo","volume":"209","author":"von Br\u00fchl","year":"2012","journal-title":"J Exp Med"},{"key":"2021091715292849700_B60","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fimmu.2012.00385","article-title":"The emerging role of neutrophils in thrombosis-the journey of TF through NETs","volume":"3","author":"Kambas","year":"2012","journal-title":"Front Immunol"},{"issue":"1","key":"2021091715292849700_B61","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12885-019-5387-9","article-title":"A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms","volume":"19","author":"Rungjirajittranon","year":"2019","journal-title":"BMC Cancer"},{"issue":"25","key":"2021091715292849700_B62","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1182\/blood-2009-08-240713","article-title":"Fetal calf serum contains heat-stable nucleases that degrade neutrophil extracellular traps","volume":"114","author":"von K\u00f6ckritz-Blickwede","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2021091715292849700_B63","doi-asserted-by":"crossref","first-page":"41749","DOI":"10.1038\/srep41749","article-title":"Transcriptional firing helps to drive NETosis","volume":"7","author":"Khan","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"2021091715292849700_B64","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/bloodadvances.2019001158","article-title":"Ruxolitinib for the prevention of thrombosis in polycythemia vera: a systematic review and meta-analysis","volume":"4","author":"Masciulli","year":"2020","journal-title":"Blood Adv"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/18\/3515\/1822603\/advancesadv2020004061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/18\/3515\/1822603\/advancesadv2020004061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T15:30:44Z","timestamp":1631892644000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/18\/3515\/476725\/Increased-levels-of-NETosis-in-myeloproliferative"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,31]]},"references-count":64,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2021,9,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020004061","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,31]]}}}